Clinical outcomes of TAVI in patients with active cancer: a bridge to success?

Back

ESC2025 Premium Access

Clinical outcomes of TAVI in patients with active cancer: a bridge to success?

Session: Cardio-oncology: new drugs, new challenges

Topic: Diagnosis and Management of Cardiovascular Disease in Patients with Cancer

Speaker: Doctor R. Carvalho (Lisbon, PT)

Event: ESC Congress 2025

Congress Presentation

Add to my library

About the speaker

Doctor Rita Carvalho

Western Lisbon Hospital Centre, EPE, Lisbon (Portugal)

5 presentations

0 follower

6 more presentations in this session

The cardioprotective effect of inhibitor sodium glucose transporter in patients undergoing chemotherapy: a systematic review and meta-analysis

Speaker: Mr J. Peres De Oliveira (BR)

Influence of the 3-omega fatty acids supplementation on the structure, regulation and vascular function of rats chronically treated with doxorubicin

Speaker: Ms M. Gaiato Monte (Botucatu, BR)

Meta-analysis and predictors of cancer therapy-related right ventricular dysfunction: insights from FAC measurements

Speaker: Doctor C. Fischer Bacca (Rio do Sul, BR)

Direct oral anticoagulants versus low-molecular-weight heparin for thromboprophylaxis in cancer-related surgeries: a meta-analysis of efficacy and safety outcomes

Speaker: Doctor K. Hosseini (Tehran, IR)

Access

Abstract

Slides

Ivabradine for prevention of anthracycline-induced cardiotoxicity: a systematic review and meta-analysis

Speaker: Mr J. Peres De Oliveira (BR)

Access the full session

Cardio-oncology: new drugs, new challenges

Speakers: Doctor R. Carvalho, Mr J. Peres De Oliveira, Ms M. Gaiato Monte, Doctor C. Fischer Bacca, Doctor K. Hosseini...

Access

About the event

ESC Congress 2025

29 August - 1 September 2025

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources

Explore sponsored resources